Compare AGMB & FISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGMB | FISI |
|---|---|---|
| Founded | 2017 | 1817 |
| Country | Belgium | United States |
| Employees | N/A | 631 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 677.9M | 643.4M |
| IPO Year | N/A | N/A |
| Metric | AGMB | FISI |
|---|---|---|
| Price | $10.50 | $34.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $32.00 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 162.1K | 100.9K |
| Earning Date | 05-14-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $33.33 | $5.22 |
| P/E Ratio | ★ N/A | $9.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.00 | $21.81 |
| 52 Week High | $17.45 | $35.47 |
| Indicator | AGMB | FISI |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 70.43 |
| Support Level | $9.71 | $26.81 |
| Resistance Level | $14.55 | $35.40 |
| Average True Range (ATR) | 1.42 | 0.67 |
| MACD | 0.03 | 0.35 |
| Stochastic Oscillator | 33.11 | 97.63 |
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Financial Institutions Inc operates through its subsidiaries, providing full range of banking services to consumer, commercial and municipal customers in Western and Central New York, and commercial loans in the Mid-Atlantic region, through a loan production office in Ellicott City, Maryland. It offers a broad range of loans including commercial business and revolving lines of credit, commercial mortgages, equipment loans, residential mortgage loans and home equity loans and lines of credit, automobile loans and personal loans. It operates in single segment of Banking.